178 related articles for article (PubMed ID: 26548419)
1. Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.
Jo W; Yu ES; Chang M; Park HK; Choi HJ; Ryu JE; Jang S; Lee HJ; Jang JJ; Son WC
Mol Med Rep; 2016 Jan; 13(1):146-52. PubMed ID: 26548419
[TBL] [Abstract][Full Text] [Related]
2. Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
Hayashi M; Tamura T; Kuroda J; Ohnota H; Shibata N; Akahane M; Kashida Y; Mitsumori K
Toxicol Sci; 2005 Mar; 84(1):22-8. PubMed ID: 15564315
[TBL] [Abstract][Full Text] [Related]
3. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
Das BK; Choukimath SM; Gadad PC
Life Sci; 2019 Aug; 230():10-18. PubMed ID: 31121175
[TBL] [Abstract][Full Text] [Related]
4. Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.
DePeralta DK; Wei L; Ghoshal S; Schmidt B; Lauwers GY; Lanuti M; Chung RT; Tanabe KK; Fuchs BC
Cancer; 2016 Apr; 122(8):1216-27. PubMed ID: 26914713
[TBL] [Abstract][Full Text] [Related]
5. Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model.
Fathy AH; Bashandy MA; Bashandy SAE; Mansour AM; Elsadek B
Can J Physiol Pharmacol; 2017 Dec; 95(12):1462-1472. PubMed ID: 28854340
[TBL] [Abstract][Full Text] [Related]
6. Exercise retards hepatocarcinogenesis in obese mice independently of weight control.
Arfianti A; Pok S; Barn V; Haigh WG; Yeh MM; Ioannou GN; Teoh NC; Farrell GC
J Hepatol; 2020 Jul; 73(1):140-148. PubMed ID: 32302728
[TBL] [Abstract][Full Text] [Related]
7. Preventive effect of caffeine and curcumin on hepato-carcinogenesis in diethylnitrosamine-induced rats.
Fujise Y; Okano J; Nagahara T; Abe R; Imamoto R; Murawaki Y
Int J Oncol; 2012 Jun; 40(6):1779-88. PubMed ID: 22293778
[TBL] [Abstract][Full Text] [Related]
8. Vanadium limits the expression of proliferating cell nuclear antigen and inhibits early DNA damage during diethylnitrosamine-induced hepatocellular preneoplasia in rats.
Chakraborty T; Chatterjee A; Dhachinamoorthi D; Srivastawa S; Panayappan L; Chatterjee M
Environ Mol Mutagen; 2006 Oct; 47(8):603-15. PubMed ID: 16878318
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
Hayashi M; Ohnota H; Tamura T; Kuroda J; Shibata N; Akahane M; Moriwaki H; Machida N; Mitsumori K
Arch Toxicol; 2004 Aug; 78(8):460-6. PubMed ID: 15034639
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive Effect of
Pocasap P; Weerapreeyakul N; Wongpoomchai R
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299510
[No Abstract] [Full Text] [Related]
11. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
12. In vitro, In silico and In vivo Antitumor Activity of Crude Methanolic Extract of Tetilla dactyloidea (Carter, 1869) on DEN Induced HCC in a Rat Model.
Krishnan GS; Rajagopal V; Antony Joseph SR; Sebastian D; Savarimuthu I; Selvaraj KRN; Thobias AF
Biomed Pharmacother; 2017 Nov; 95():795-807. PubMed ID: 28892791
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
15. Roxithromycin inhibits constitutive activation of nuclear factor {kappa}B by diminishing oxidative stress in a rat model of hepatocellular carcinoma.
Ueno S; Aoki D; Kubo F; Hiwatashi K; Matsushita K; Oyama T; Maruyama I; Aikou T
Clin Cancer Res; 2005 Aug; 11(15):5645-50. PubMed ID: 16061884
[TBL] [Abstract][Full Text] [Related]
16. Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver.
Lee TY; Kim KT; Han SY
Korean J Hepatol; 2007 Mar; 13(1):70-80. PubMed ID: 17380077
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model.
Miki A; Yano Y; Kato H; Seo Y; Kuriyama M; Azuma T; Hayashi Y
Int J Oncol; 2008 Mar; 32(3):603-8. PubMed ID: 18292937
[TBL] [Abstract][Full Text] [Related]
18. Ductular reaction, cytokeratin 7 positivity, and gamma-glutamyl transferase in multistage hepatocarcinogenesis in rats.
Moreira AJ; Rodrigues GR; Bona S; Fratta LX; Weber GR; Picada JN; Dos Santos JL; Cerski CT; Marroni CA; Marroni NP
Protoplasma; 2017 Mar; 254(2):911-920. PubMed ID: 27525410
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effects of cimetidine on hepatocellular carcinomas in diethylnitrosamine-treated rats.
Furuta K; Sato S; Miyake T; Okamoto E; Ishine J; Ishihara S; Amano Y; Adachi K; Kinoshita Y
Oncol Rep; 2008 Feb; 19(2):361-8. PubMed ID: 18202782
[TBL] [Abstract][Full Text] [Related]
20. Panax ginseng exerts antiproliferative effects on rat hepatocarcinogenesis.
Kim H; Lee HJ; Kim DJ; Kim TM; Moon HS; Choi H
Nutr Res; 2013 Sep; 33(9):753-60. PubMed ID: 24034575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
